The Special Interest Group (SIG) in Cardiology Pharmacy within European Society of Clinical Pharmacy (ESCP) strives to promote excellence in cardiology pharmacy practice. Our primary goals is to provide a platform for fostering specialized knowledge by providing educational resources focused on cardiology pharmacotherapy. We aim to facilitate networking and collaboration among researchers, academic professionals and healthcare professionals, advocating the role of clinical pharmacist in providing patient-centred care.

Moreover, we stay up-to-date of regulatory updates, encourage research, and emphasize evidence-based practices. Through outreach initiatives and professional development opportunities, we seek to enhance public awareness and advocate for the recognition and integration of cardiology pharmacy services within healthcare systems. By focusing on these objectives, our group aims to contribute significantly to the evolution and impact of cardiology pharmacy within the clinical pharmacy landscape.


The Special Interest Group (SIG) in Cardiology Pharmacy was established through the visionary efforts of key individuals, spearheaded by Imran Iqbal in 2023. Recognizing the need for a specialized platform within our clinical pharmacy organization, Imran Iqbal collaborated with dedicated professionals from different corners of the world, Adam Livori, Furqan K. Hashmi, and Ali Raza Qureshi to make this interest group a reality. Their shared commitment to advancing expertise in cardiology pharmacy, coupled with a passion for patient-centred care, fuelled the formation of SIG Cardiology. Together, Imran Iqbal, Adam Livori, Furqan Hashmi, and Ali Raza Qureshi laid the foundation for a dynamic community that promotes collaboration, education, and advocacy in the field of cardiology pharmacy within our clinical pharmacy organization. 

Imran Iqbal
Bachelor of Science (B.Sc.) | University of the Punjab, Lahore Pakistan
Doctor of Pharmacy (PharmD) | University of the Punjab, Lahore Pakistan
M.Sc. (Toxicology) | University of Eastern Finland, Kuopio, Finland
PhD researcher |University of Turku, Turku, Finland

Dr. Imran Iqbal is an accomplished researcher with a diverse academic backgrounds and a profound commitment to advancing our understanding of cardiovascular health. Holding a Bachelor of Science (B.Sc.) degree, Imran Iqbal pursued a Doctor of Pharmacy (PharmD) qualification, followed by the attainment of a Master’s degree (M.Sc.) in Toxicology, demonstrating a strong foundation in both pharmaceutical sciences and molecular mechanisms. 
Previously, Imran Iqbal has worked as clinical pharmacist in a 300-bed teaching hospital where he was actively involved in the patient care. He has been supervising hospital pharmacy services, drug information services, and pharmacy staff. He has mentored many pharmacy interns. Currently, Imran Iqbal is undertaking doctoral research, focusing on myocardial infarction (MI) and molecular imaging techniques. With a meticulous approach and a passion for scientific inquiry, Imran Iqbal aims to elucidate the intricate molecular pathways underlying heath disease. By leveraging state-of-the-art imaging technologies, Imran Iqbal seeks to contribute valuable insights into the diagnosis and treatment of cardiovascular conditions, with the ultimate goal of improving patient care and outcomes.

Furqan K. Hashmi 
Pharmacy (B. Pharmacy, University of the Punjab, Lahore Pakistan
Master of Science (M.Sc) in Clinical Pharmacy, University of New South Wales, Sydney, Australia
Ph.D. Pharmacy Practice, Universiti Sains Malasia, Penang, Malaysia

Professor Dr. Furqan K. Hashmi is currently working as Head of the department of pharmacy practice and the professor of pharmacy practice, where he is involved in teaching and research mentoring at undergraduate as well as postgraduate levels. His doctoral thesis examines the extended pharmacy services offered by community pharmacies in Pakistan using a mix-method design (qualitative and quantitative methods). 
Prof. Dr. Furqan K. Hashmi has particular emphasis on the outcome and healthcare services research involving social and administrative aspects of healthcare. He seeks to engage students by examining ways they can actively participate in discussions often using innovative collaborative platforms. He interact with students ascertaining their research direction and assisting in the composition of their theories and experiments.

Research interest includes: 
– Pharmacy education
– Pharmaceutical policy and practice
– Patient adherence to cardiology medication
– Pharmacovigilance and drug safety 
– Extended Community Pharmacy and Value-added Services
– Antimicrobial Resistance in Pakistan

Adam Livori BAppSci(NucMed), BPharm(Hons), MClinPharm, FSHP, FANZCAP (Cardiol. Research)

Adam Livori is a cardiac clinician-researcher currently completing his PhD in pharmacoepidemiology, health economics and translational science. He holds degrees in Nuclear Medicine and clinical pharmacy. He works clinically as consultant cardiology pharmacist at Grampians Health, overseeing clinical pharmacy services in across internal medicine and cardiology. His research interests include applied biostatistics and health economic analysis. He is passionate about open-source science and currently holds research funding under Safer Care Victoria, and collaborates between CMUS and the Victorian Heart Institute. His PhD title is “Patterns and predictors of clinical outcomes in myocardial infarction and atrial fibrillation.

Ali Raza Qureshi
Doctor of Pharmacy (PharmD), R.Ph.
Masters of Business Administration (MBA) | DeVry University New York, NY, US
Global Pharmacovigilance | Coordinator PV Reporting Coordinator
Global Regulatory Department – VMRD, Zoetis, Michigan, US 

Dr. Ali Raza Qureshi is working at Zoetis – Regulatory Affairs – Pharmacovigilance reporting coordinator. He hold Doctor of Pharmacy (PharmD) and MBA from DeVry University of New York. 
His work as a senior pharmacovigilance coordinator, knowns as eyes and ears of pharmaceutical companies, includes the responsibilities ranging from developing reports of adverse drug events that may involve complex medical terminology, medical chart reviews, and statistical analyses. In in current role, he is in-charge of monitoring potential adverse effects of drugs being marketed in the United States and distributed in Europe, Australia, New Zealand continent by reviewing case studies and medical literature. Reviewing data on patient outcomes and identifying trends that indicate a need for further investigation is an interesting part of his daily working. Most importantly, he work to ensure that all relevant necessary information is properly documented and available if it’s needed in the future. Dr. Ali Raza Qureshi is very passionate about his role in pharmacovigilance in drug development and to promote safe use of medicines.

ESCP Members can fill in an application form for the respective SIG via the forms available on this page
Click here for the application form.

Next Events: Will be announced soon (links of subscription form if exist)

Projects/Research: Will be announced soon.

Reports (only for members): Will be announced soon.